OmniAb (OABI) Total Current Liabilities (2021 - 2026)
OmniAb's (OABI) quarterly Total Current Liabilities came in at $13.6 million in Q1 2026, up 18.93% year-on-year from $11.4 million in Q1 2025, and down 16.54% on a QoQ basis from $16.3 million in Q4 2025.
OmniAb (OABI) Total Current Liabilities (2021 - 2026) Analysis & Trends
OmniAb (OABI) has 6 years of Total Current Liabilities data on file, last reported at $13.6 million in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 18.93% year-over-year to $13.6 million in Q1 2026; TTM through Mar 2026 was $13.6 million, a 18.93% increase from a year earlier, with the FY2025 full-year figure at $16.3 million, up 7.73% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $13.6 million, down from $16.3 million in the prior quarter.
- Over the last five years, Total Current Liabilities for OABI reached as high as $26.0 million in Q4 2022 and fell as low as $5.5 million in Q1 2022.
- Historically, Total Current Liabilities has averaged $15.9 million across 5 years, with a median of $14.4 million in 2024.
- Across the five-year window, Total Current Liabilities surged 10598.67% in 2022 and sank 42.53% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $26.0 million in 2022, then decreased by 11.17% to $23.1 million in 2023, then slumped by 34.73% to $15.1 million in 2024, then climbed by 7.73% to $16.3 million in 2025, then retreated by 16.54% to $13.6 million in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $13.6 million in Q1 2026, $16.3 million in Q4 2025, and $13.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 56.01 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 66.94 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 1.81 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 6.38 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 3.88 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5.11 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.58 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 289.60 Mn |
| 10 | OmniAb | 261.62 Mn | 212.55 Mn | 14.41 Mn | 13.57 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 13.57 Mn |
| Dec 31, 2025 | 16.25 Mn |
| Sep 30, 2025 | 13.28 Mn |
| Jun 30, 2025 | 12.64 Mn |
| Mar 31, 2025 | 11.41 Mn |
| Dec 31, 2024 | 15.09 Mn |
| Sep 30, 2024 | 14.40 Mn |
| Jun 30, 2024 | 14.15 Mn |
| Mar 31, 2024 | 17.52 Mn |
| Dec 31, 2023 | 23.12 Mn |
| Sep 30, 2023 | 25.06 Mn |
| Jun 30, 2023 | 24.24 Mn |
| Mar 31, 2023 | 21.68 Mn |
| Dec 31, 2022 | 26.02 Mn |
| Sep 30, 2022 | 10.27 Mn |
| Jun 30, 2022 | 6.98 Mn |
| Mar 31, 2022 | 5.46 Mn |
| Dec 31, 2021 | 20.58 Mn |
| Sep 30, 2021 | 95,969.00 |